Market Research Reports, Inc. has announced the addition of “Global Pompe Disease Treatment Market 2016 - 2020” research report to their website www.MarketResearchReports.com

Lewes, DE -- (SBWire) -- 01/10/2017 --Report forecast the global Pompe disease treatment market to grow at a CAGR of 11.85% during the period 2016-2020.

Lysosomal storage diseases (LSDs) are a group of progressive, autosomal recessive, and hereditary disorders characterized by the accumulation of specific substrates and variable age of onset and clinical symptoms. Pompe disease, a type of LSD, is caused by mutations in the GAA gene. These mutations inhibit the mechanism of action (MOA) of GAA; it is an enzyme responsible for catabolizing glycogen, resulting in accumulation of glycogen to toxic levels in the lysosomes of the cells. The buildup of glycogen in certain tissues and organs, especially in the muscles, hinders the normal functions of the organs.

It can be further divided as adult-onset and infantile-onset Pompe diseases. As the disease is an autosomal recessive hereditary disorder, both parents are carriers and pass one copy of the mutated gene to their offspring. It affects both women and men across all ethnicities and races and has a varied age of onset of symptoms. Till date, researchers have identified over 300 genetic mutation types that lead to disease manifestation. Though there is no known cure for Pompe disease, enzyme replacement therapy (ERT) and diet therapy have been effective in reducing its clinical manifestations.

The report covers the present scenario and the growth prospects of the global Pompe disease treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the drugs available in the market and the drug candidates that are in various phases of development for the treatment of Pompe disease.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

According to the report, the US FDA's OOPD aims to develop and evaluate biologics, drugs, and devices that effectively cure and diagnose rare diseases, and extends benefits to underlying companies. It also grants orphan status to biologics and drugs proven to be effective and safe in treating rare diseases. The Orphan Products Clinical Trials Grants Program funds the clinical research tests to check the efficacy and safety of drugs, medical devices, and biologics.

Further, the report states that various events and fundraising programs are being organized by government and non-government organizations to raise awareness and educate people about the Pompe disease and its diagnosis and treatment options resulting in social and economic benefits and improvement in patients' quality of life. Organizations such as the United Pompe Foundation, International Pompe Association, Canadian Association of Pompe, Acid Maltase Deficiency Association, and National Organization for Rare Disorders (NORD) are involved in promoting various events online and offline to spread awareness.

Global Pompe Disease Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global Pompe disease treatment market: Amicus Therapeutics, Audentes Therapeutics, and Sanofi-Genzyme

Other Prominent Vendors in the market are: EpiVax, Oxyrane, Sangamo BioSciences, and Valerion Therapeutics

Market driver
- Special regulatory drug designations for orphan drugs
- For a full, detailed list, view our report

Market challenge
- Limited patient population
- For a full, detailed list, view our report

Market trend
- Emergence of immunotherapy for Pompe disease
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 65 pages and 51 Exhibits "Global Pompe Disease Treatment Market 2016 - 2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Disease overview, Market segmentation by type of Pompe disease, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.marketresearchreports.com/technavio/global-pompe-disease-treatment-market-2016-2020

Related Reports;

Global Hypodermic Needles Market 2016-2020 - Visit at - http://www.marketresearchreports.com/technavio/global-hypodermic-needles-market-2016-2020

Global Thrombectomy Devices Market 2016-2020 - Visit at - http://www.marketresearchreports.com/technavio/global-thrombectomy-devices-market-2016-2020

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions